Lutetium-177 Radiolabeled Antibodies for the Treatment of CNS Malignancies

$210,511P50FY2004NSNIH

Duke University, Durham NC

Investigators

Michael Rod Zalutsky

Linked publications, trials & patents

Paper 26759007 Paper 25843513 Paper 25762141 Paper 25312738 Paper 24939611 Paper 24776093 Paper 24722266 Paper 24722048 Paper 24570975 Paper 24460937 Paper 24373972 Paper 24075405 Paper 24054399 Paper 23982483 Paper 23924792 Paper 23857604 Paper 23837761 Paper 23806556 Paper 23634286 Paper 23591978 Paper 23581583 Paper 23530248 Paper 23527092 Paper 23280793 Paper 23248284 Paper 23159039 Paper 23132717 Paper 23115013 Paper 23052252 Paper 23037712 Paper 22964392 Paper 22899282 Paper 22869205 Paper 22727691 Paper 22535433 Paper 22407177 Paper 22400035 Paper 22383993 Paper 22371319 Paper 22346349 Paper 22241217 Paper 22202151 Paper 22201707 Paper 21997879 Paper 21986722 Paper 21961046 Paper 21958852 Paper 21938530 Paper 21817013 Paper 21809989 Paper 21744079 Paper 21729780 Paper 21719641 Paper 21590689 Paper 21590380 Paper 21531816 Paper 21466382 Paper 21464146 Paper 21430586 Paper 21291403 Paper 21243098 Paper 21233176 Paper 21220131 Paper 21149254 Paper 21149252 Paper 21119888 Paper 21087515 Paper 20921459 Paper 20870149 Paper 20853132 Paper 20824708 Paper 20809959 Paper 20718706 Paper 20716591 Paper 20472715 Paper 20443129 Paper 20424975 Paper 20414475 Paper 20210709 Paper 20150978 Paper 20030624 Paper 20025498 Paper 19944071 Trial NCT01009866 Trial NCT00643097 Trial NCT00636805 Trial NCT00301873 Patent 9974848 Patent 8541568 Patent 6455498 Patent 6127126 Patent 5981725 Patent 5814317 Patent 5710010 Patent 5624659 Patent 5558852 Patent 5407925 Patent 5401828 Patent 5316932 Patent 5212290

View original record on NIH RePORTER →